Home › Merck to Present New Data Analyses of its Investigational Ragweed Pollen and Grass Pollen Allergy Immunotherapy Tablets
 

Keywords :   


Merck to Present New Data Analyses of its Investigational Ragweed Pollen and Grass Pollen Allergy Immunotherapy Tablets

2013-02-22 14:30:00| Merck.com - Research & Development News

Dateline City:  WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that researchers will present new data analyses of the safety and efficacy of the companys investigational allergy immunotherapy tablets (AITs) for ragweed pollen (Ambrosia artemisiifolia) and grass pollen (Phleum pratense) at the 2013 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting. The meeting will be held in San Antonio from February 22-26. Language:  English Contact HTML:  MerckMedia:Pam Eisele, 908-423-5042orLesley Brown, 267-305-3545orInvestor:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088 Ticker Slug:  Ticker: MRK Exchange: NYSE read more

Tags: data present analyses grass

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
17.05Henkel Laundry Patent Details Transfer of Encapsulated Fragrance with Dryer Balls
17.05This Week in Waste: Top Stories May 13 May 16, 2024
17.05New Pizza Box Recycling Bins Rolling Out in Central Park, Aiming to Limit Rodent Issues
17.05WM Celebrates Completion of $23 Million in Upgrades at Pittsburgh Facility
17.05Bioenergy Devco's Maryland Bioenergy Center Recycles Food Waste at Full Nameplate Capacity
17.05PNWSCT Coatings Fest 2024 Issues Call for Papers
17.05USDA awards $22.2 million to protect livestock health
17.05USDA awards $22.2 million to protect livestock health
More »